MTOR and acute lymphoblastic leukemia: Treatment of B-ALL cells with the CK2 inhibitor, CX-4945, along with scrambled shRNA, resulted in reduced transcription of the MTOR gene; however, IKZF1 knockdown with shRNA was able to rescue CX-4945-mediated repression of MTOR in both cell lines (Fig. 3f).